Published in J Neuroimmunol on February 03, 2016
Neurobehavioral Abnormalities in the HIV-1 Transgenic Rat Do Not Correspond to Neuronal Hypometabolism on 18F-FDG-PET. PLoS One (2016) 0.77
Fate of microglia during HIV-1 infection: From activation to senescence? Glia (2016) 0.75
Lactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic Escherichia coli K1 infection by accelerating development of intestinal defense. Sci Rep (2017) 0.75
MR brain volumetric measurements are predictive of neurobehavioral impairment in the HIV-1 transgenic rat. Neuroimage Clin (2017) 0.75
CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci (2001) 4.12
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res (2000) 3.84
Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann Neurol (2010) 2.96
Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol (2003) 2.93
Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol (2000) 2.72
NeuN: a useful neuronal marker for diagnostic histopathology. J Histochem Cytochem (1996) 2.29
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A (2001) 2.28
Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology (2013) 1.88
The neuropathogenesis of HIV-1 infection. J Leukoc Biol (1994) 1.83
Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia (2002) 1.80
Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol (2009) 1.75
CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol (2009) 1.73
HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J (1991) 1.66
The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment. Retrovirology (2011) 1.42
MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB J (2010) 1.39
Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology (2003) 1.39
New generation humanized mice for virus research: comparative aspects and future prospects. Virology (2013) 1.38
Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J Neurovirol (2004) 1.38
Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus. Cell Tissue Res (2011) 1.38
Neuropathology of early HIV-1 infection. Brain Pathol (1996) 1.37
Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage (2008) 1.35
Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. AIDS (2012) 1.32
Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem (2004) 1.29
Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. J Neurosci (2011) 1.22
The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol (2009) 1.21
Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr (2013) 1.21
Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neurovirol (2009) 1.20
Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol (2007) 1.18
Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J Neurovirol (2010) 1.16
HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes Infect (2002) 1.10
Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol (2008) 1.09
Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am J Pathol (2010) 1.09
HIV-1-transgene expression in rats decreases alveolar macrophage zinc levels and phagocytosis. Am J Respir Cell Mol Biol (2008) 1.08
Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine. Immunol Invest (2011) 1.04
HIV-1 immunopathogenesis in humanized mouse models. Cell Mol Immunol (2012) 1.03
Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport. Neurotox Res (2011) 1.03
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. J Neuroimmunol (2012) 1.02
HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes. Neurobiol Dis (2011) 1.01
HIV-1 gp120 and drugs of abuse: interactions in the central nervous system. Curr HIV Res (2012) 0.98
Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J Neuroimmune Pharmacol (2009) 0.97
Retracted Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats. J Cereb Blood Flow Metab (2010) 0.97
Marked Strain-Specific Differences in the SU5416 Rat Model of Severe Pulmonary Arterial Hypertension. Am J Respir Cell Mol Biol (2016) 0.95
Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Curr HIV Res (2012) 0.95
Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction. Exp Neurol (2012) 0.94
Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat. J Neuroimmune Pharmacol (2009) 0.93
Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine. Curr HIV Res (2015) 0.91
Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation. J Neurovirol (2013) 0.90
Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection. J Neuroimmune Pharmacol (2013) 0.90
Neuronal cell cycle: the neuron itself and its circumstances. Cell Cycle (2015) 0.90
Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures. Mol Cell Neurosci (2012) 0.89
Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Mol Neurodegener (2014) 0.87
Time and time again: temporal processing demands implicate perceptual and gating deficits in the HIV-1 transgenic rat. J Neuroimmune Pharmacol (2013) 0.87
The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun (2015) 0.87
Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats. Pharmacol Biochem Behav (2011) 0.87
Diffusion tensor and volumetric magnetic resonance measures as biomarkers of brain damage in a small animal model of HIV. PLoS One (2014) 0.86
Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage. J Neurovirol (2009) 0.86
Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat. J Neurovirol (2010) 0.85
Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease. J Neuroinflammation (2010) 0.85
Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro. J Virol (2003) 0.85
Neuronal toxicity in HIV CNS disease. Future Virol (2012) 0.85
Form follows function: astrocyte morphology and immune dysfunction in SIV neuroAIDS. J Neurovirol (2014) 0.84
Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine. J Neurovirol (2010) 0.84
Astrocytes repress the neuronal expression of GLAST and GLT glutamate transporters in cultured hippocampal neurons from embryonic rats. Neurochem Int (2004) 0.83
Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats. PLoS One (2014) 0.83
Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice. Mol Neurodegener (2014) 0.82
Expression of ATP-binding cassette membrane transporters in a HIV-1 transgenic rat model. Biochem Biophys Res Commun (2014) 0.81
Neuroanatomical phenotyping in the mouse: the dopaminergic system. Vet Pathol (2005) 0.81
Modeling deficits in attention, inhibition, and flexibility in HAND. J Neuroimmune Pharmacol (2014) 0.81
Pharmacogenetic heterogeneity of transgene expression in muscle and tumours. BMC Pharmacol (2003) 0.80
Imaging dopaminergic dysfunction as a surrogate marker of neuropathology in a small-animal model of HIV. Mol Imaging (2014) 0.80
HIV-1 proteins, Tat and gp120, target the developing dopamine system. Curr HIV Res (2015) 0.80
Effects of vitamin A deficiency and opioids on parvalbumin + interneurons in the hippocampus of the HIV-1 transgenic rat. Curr HIV Res (2012) 0.80
Astrocytic expression of HIV-1 viral protein R in the hippocampus causes chromatolysis, synaptic loss and memory impairment. J Neuroinflammation (2014) 0.79
Astrocyte Dysfunctions and HIV-1 Neurotoxicity. J AIDS Clin Res (2013) 0.79
HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging. PLoS One (2014) 0.79
Lewis, Fischer 344, and sprague-dawley rats display differences in lipid peroxidation, motor recovery, and rubrospinal tract preservation after spinal cord injury. Front Neurol (2015) 0.77
Effects of amphetamine on striatal dopamine release, open-field activity, and play in Fischer 344 and Sprague-Dawley rats. Behav Pharmacol (2015) 0.76
Physicochemical characterization of ferumoxytol, heparin and protamine nanocomplexes for improved magnetic labeling of stem cells. Nanomedicine (2016) 0.78
Superparamagnetic iron oxide nanoparticles for direct labeling of stem cells and in vivo MRI tracking. Contrast Media Mol Imaging (2015) 0.78
Lack of neuroinflammation in the HIV-1 transgenic rat: an [(18)F]-DPA714 PET imaging study. J Neuroinflammation (2015) 0.78